India to Malaysia: Everolimus Export Trade Route
India has recorded 4 verified shipments of Everolimus exported to Malaysia, representing a combined trade value of $425.5K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $106.4K USD. The leading Indian exporter is BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, which accounts for 100% of total export value with 2 shipments worth $424.8K USD. On the buying side, SUNIME LIMITED is the largest importer in Malaysia with $424.8K USD in purchases. The top 3 suppliers — BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, M/S MERCURY MEDICARE, BABA AGENCIES — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Malaysia Everolimus corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $425.5K USD. The route is dominated by BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's everolimus manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $106.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with everolimus's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 11.9%, placing it at rank #6 among India's top everolimus export destinations globally.
On the import side, key buyers of Indian everolimus in Malaysia include SUNIME LIMITED, EFS LOGISTICS SDN BHD, NILA JAMAL ENTERPRISE . SUNIME LIMITED is the single largest importer with 2 shipments valued at $424.8K USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ1
- Primary modeSea freight
- Top portCHENNAI AIR CARGO ACC (INMAA4)
Market Position
- Global rank#6
- Annual growth+11.9%
- Demand growth+12.4%
- Regulatory ease71/100
Top 10 Indian Everolimus Exporters to Malaysia
Showing top 10 of 3 Indian suppliers exporting Everolimus to Malaysia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED Avg $212.4K per shipment | 2 | $424.8K | 99.8% |
| 2 | M/S MERCURY MEDICARE Avg $607 per shipment | 1 | $607 | 0.1% |
| 3 | BABA AGENCIES Avg $111 per shipment | 1 | $111 | 0.0% |
This table shows the top 10 of 3 Indian companies exporting everolimus to Malaysia, ranked by total trade value. The listed exporters are: BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, M/S MERCURY MEDICARE, BABA AGENCIES . BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED is the dominant supplier with 2 shipments worth $424.8K USD, giving it a 100% market share.
Top 10 Everolimus Importers in Malaysia
Showing top 10 of 3 known buyers in Malaysia receiving Everolimus shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian everolimus in Malaysia include SUNIME LIMITED, EFS LOGISTICS SDN BHD, NILA JAMAL ENTERPRISE . The largest importer is SUNIME LIMITED, accounting for $424.8K USD across 2 shipments — representing 100% of all everolimus imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUNIME LIMITED | 2 | $424.8K | 99.8% |
| 2 | EFS LOGISTICS SDN BHD | 1 | $607 | 0.1% |
| 3 | NILA JAMAL ENTERPRISE | 1 | $111 | 0.0% |
Top 10 Everolimus Formulations Imported by Malaysia
Showing top 10 of 4 product formulations shipped on the India to Malaysia Everolimus route, ranked by trade value
Malaysia imports a wide range of everolimus formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — EVEROLIMUS GRANULES 3.33% W/W OTHER TAX DOCUMENT MH1160000396 DTD. 28.11.2023 — accounts for $424.8K USD across 1 shipments. A total of 4 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVEROLIMUS GRANULES 3.33% W/W OTHER TAX DOCUMENT MH1160000396 DTD. 28.11.2023 | 1 | $424.8K | 99.8% |
| 2 | EVERMIL 10MG TAB (EVEROLIMUS) (BATCH NO | 1 | $607 | 0.1% |
| 3 | EVERMIL-10MG (EVEROLIMUS TABLETS 10MG ) | 1 | $111 | 0.0% |
| 4 | EVEROLIMUS GRANULES 3.33% W/W 100 MG ASFOC | 1 | $0 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 70%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
CHENNAI AIR CARGO ACC (INMAA4) handles the highest volume with 2 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's everolimus exports to Malaysia are driven primarily by a handful of large-scale manufacturers. BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Malaysia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, M/S MERCURY MEDICARE, BABA AGENCIES — together account for 100% of total trade value on this route. The average shipment value of $106.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as evermil 10mg tab (everolimus) (batch no and evermil-10mg (everolimus tablets 10mg ) , suggesting that buyers in Malaysia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUNIME LIMITED is the largest importer with 2 shipments worth $424.8K USD — representing 100% of all everolimus imports from India on this route.
Route Statistics
- Trade Volume
- $425.5K
- Avg. Shipment
- $106.4K
- Suppliers
- 3
- Buyers
- 3
- Transit (Sea)
- ~34 days
- Annual Growth
- +11.9%
Related Analysis
Reverse Direction
Malaysia → India — Everolimus (Import)Other Everolimus Routes
Unlock the Full India to Malaysia Everolimus Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 4 shipments on this route.
Frequently Asked Questions — India to Malaysia Everolimus Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Everolimus to Malaysia?
The leading Indian exporters of Everolimus to Malaysia are BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, M/S MERCURY MEDICARE, BABA AGENCIES . BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Everolimus exports from India to Malaysia?
India exports Everolimus to Malaysia worth approximately $425.5K USD across 4 recorded shipments. The average value per shipment is $106.4K USD.
Q Which ports does India use to ship Everolimus to Malaysia?
The most active port of origin is CHENNAI AIR CARGO ACC (INMAA4) with 2 shipments. Indian exporters primarily use sea freight for this route, with 70% of shipments going by sea and 19% by air.
Q How long does shipping take from India to Malaysia for Everolimus?
The average transit time for Everolimus shipments from India to Malaysia is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Malaysia Everolimus trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 11.9% with demand growth tracking at 12.4%. The route is ranked #6 among India's top Everolimus export destinations globally.
Q How many suppliers are active on the India to Malaysia Everolimus route?
There are currently 3 active Indian suppliers exporting Everolimus to Malaysia. The market is moderately concentrated with BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Everolimus from India in Malaysia?
The leading importers of Indian Everolimus in Malaysia include SUNIME LIMITED, EFS LOGISTICS SDN BHD, NILA JAMAL ENTERPRISE . SUNIME LIMITED is the largest buyer with 2 shipments worth $424.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Malaysia export trade corridor identified from Indian Customs (DGFT) records for Everolimus.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 3 importers in Malaysia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 4 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists